Loading...
Products:Signal Transduction >> Protein Trafficking >> Nuclear Import / Export
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-MVP antibody [LMR5]
See all MVP products (11) ...
Rat monoclonal [LMR5] to MVP
Flow Cyt, IHC-P, IHC-Frmore details
Reacts with
Human
Tissue / cell preparation; 2R120 cell line, derived by stepwise Doxorubicin exposure of the SW-1573 non-small cell lung carcinoma cell line.
Positive tissue - Cell Lines: Drug-sensitive parental cell lines and their multidrugresistant derivatives. Negative control antibody: Normal rat serum.
Liquid
Store at +4°C.
Preservative: 0.1% Sodium Azide
Constituents: 1% BSA
Tissue culture supernatant
Monoclonal
LMR5
IgG
Cancer >> Drug resistance >> Vault proteins
Signal Transduction >> Protein Trafficking >> Nuclear Import / Export
Our Abpromise guarantee covers the use of ab3374 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Flow Cyt: use at a diluton of 1/20 - 1/30. Cell permeabilization required.
IHC-P: use at a diluton of 1/20 - 1/30.
IHC-Fr: use at a diluton of 1/20 - 1/30.
Not tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
Required for normal vault structure. Vaults are multi-subunit structures that may act as scaffolds for proteins involved in signal transduction. Vaults may also play a role in nucleo-cytoplasmic transport. Down-regulates INFG-mediated STAT1 signaling and subsequent activation of JAK. Down-regulates SRC activity and signaling through MAP kinases.
Present in most normal tissues. Higher expression observed in epithelial cells with secretory and excretory functions, as well as in cells chronically exposed to xenobiotics, such as bronchial cells and cells lining the intestine. Overexpressed in many multidrug-resistant cancer cells.
Contains 9 MVP (vault) repeats.
MVP 3 mediates interaction with PTEN.
MVP 4 mediates interaction with PARP4.
Phosphorylated on Tyr residues after EGF stimulation.
Dephosphorylated by PTPN11.
Cytoplasm. Nucleus > nuclear pore complex. 5% found in the nuclear pore complex. Translocates from the nucleus to the cytoplasm upon EGF treatment.
Target information above from: UniProt accessionQ14764
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
This product has been referenced in:
See all 2 publications for this product
Publishing research using ab3374? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
